ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %

University Hospital, Brest · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
celllungcancerchemotherapypembrolizumabsmall
non-small-cell lung cancer, pdl1≥50%, advanced stage, pembrolizumab, chemotherapy-pembrolizumab combination, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 982245
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.